ANI Pharmaceuticals Inc. (ANIP)
NASDAQ: ANIP
· Real-Time Price · USD
93.37
-1.62 (-1.71%)
At close: Sep 25, 2025, 3:59 PM
93.00
-0.40%
After-hours: Sep 25, 2025, 04:51 PM EDT
-1.71% (1D)
| Bid | 89.8 |
| Market Cap | 2.03B |
| Revenue (ttm) | 747.4M |
| Net Income (ttm) | -11.03M |
| EPS (ttm) | -0.69 |
| PE Ratio (ttm) | -135.32 |
| Forward PE | 12.02 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 100 |
| Volume | 200,973 |
| Avg. Volume (20D) | 468,866 |
| Open | 94.95 |
| Previous Close | 94.99 |
| Day's Range | 92.97 - 95.12 |
| 52-Week Range | 52.50 - 99.50 |
| Beta | 0.63 |
| Ex-Dividend Date | n/a |
About ANIP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANIP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANIP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsANI Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 7, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+18.07%
ANI Pharmaceuticals shares are trading higher afte...
Unlock content with
Pro Subscription
6 months ago
+13.39%
ANI Pharmaceuticals shares are trading higher after the company reported better-than-expected Q4 financial results.
1 month ago · seekingalpha.com
ANI Pharmaceuticals, Inc. (ANIP) Q2 2025 Earnings Call TranscriptANI Pharmaceuticals, Inc. (NASDAQ:ANIP ) Q2 2025 Earnings Conference Call August 8, 2025 8:30 AM ET Company Participants Christopher K. Mutz - Senior VP & Head of Rare Disease Nikhil Lalwani - Preside...
